Introduction: Population of people over 65 years old is one of the groups of the greatest risk of suicide attempt. In this age range the highest suicide rate that results in death is observed. Metabolism alterations and co-morbidities development with age may play major role in increasing suicide rate. Accidental and intentional drug over-ingestions are more common for people with numerous prescriptions and comorbid conditions. Overdose in such patients can pose great threat to patients life.
Aim of the study: The purpose of this study is to depict course of β-adrenolitics and benzodiazpines poisoning on the base of case report.
Materials and methods: The analysis of the patient's medical history and the review of available literature in the PubMed and Google Scholar databases.
Results: The 65-year-old female, was brought by emergency medical services to the Toxicology Clinic due severe drug poisoning. Upon admission patient was unconscious, intubated, on ventilator, in overall severe condition. She presented symptoms of circulatory insufficiency. History revealed overdose of β-adrenolitics and benzodiazepines. The application of proper pharmacological treatment and heart pacing resulted in gradual improvement of patients condition. After one-week stay she was discharged home in good condition.
Conclusions: Course of β-adrenolitics poisoning with addition of benzodiazepines poses great threat, especially when one suffers from numerous comorbidities. Therefore, due to wider availability of drugs and rising number of suicide attempts, as well as events of medication errors, it is crucial to be aware of elder people problems and prevent such situations.

Betaadrenolitic; betablocker; bisoprolol; estazolam; overdose;

Hashiyada M, Usui K, Hayashizaki Y, Hosoya T, Igari Y, Sakai J, et al. Unexpectedly high blood concentration of bisoprolol after an incorrect prescription: A case report. Leg Med. 2013;15(2):103–5.

DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23(4):223–38.

Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016;81(3):453–61.

Sigaroudi A, Kinzig M, Wahl O, Stelzer C, Schroeter M, Fuhr U, et al. Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples. Pharmacology. 2018;101(1–2):29–34.

Brodde O-E, Kroemer H. Drug-Drug Interactions of β-Adrenoceptor Blockers. Arzneimittelforschung. 2011;53(12):814–22.

Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013. Am J Public Health. 2016;106(4):686–8.

Almoznino G, Haviv Y, Sharav Y, Benoliel R. An update of management of insomnia in patients with chronic orofacial pain. Oral Dis. 2017;23(8):1043–51.

Mancinelli A, Guiso G, Garattini S, Urso R, Caccia S. Kinetic and pharmacological studies on estazolam in mice and man. Xenobiotica. 1985;15(3):257–65.

Vijayakumar L. Suicide in women. Indian J Psychiatry. 2015;57(Suppl 2):S233-8.

Ramdas S, Riesenberg LA, Jasani N. Drug overdose with refractory bradycardia and hypotension. Del Med J. 2011;83(6):169–72.

Truhlář A, Deakin CD, Soar J, Khalifa GEA, Alfonzo A, Bierens JJLM, et al. European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015;95:148–201.

Shepherd G. Treatment of poisoning caused by β-adrenergic and calcium-channel blockers. Am J Heal Pharm. 2006;63(19):1828–35.

Thanacoody R, Caravati EM, Troutman B, Höjer J, Benson B, Hoppu K, et al. Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol. 2015;53(1):5–12.

Lafarge L, Bourguignon L, Bernard N, Vial T, Dehan-Moya M-J, De La

Gastine B, et al. Facteurs de risque pharmacocinétiques de surdosage en bêta-bloquants chez les patients âgés : cas clinique et rationnel pharmacologique. Ann Cardiol Angeiol (Paris). 2018;67(2):91–7.

Taboulet P, Cariou A, Berdeaux A, Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. J Toxicol Clin Toxicol. 1993;31(4):531–51.

Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol. 2003;41(5):595–602.

Peterson CD, Leeder JS, Sterner S. Glucagon therapy for beta-blocker overdose. Drug Intell Clin Pharm. 1984;18(5):394–8.

Jang DH, Spyres MB, Fox L, Manini AF. Toxin-Induced Cardiovascular Failure. Emerg Med Clin North Am. 2014;32(1):79–102.

Walter E, McKinlay J, Corbett J, Kirk-Bayley J. Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. J Intensive Care Soc. 2018;19(1):50.

van Nunen LX, Noc M, Kapur NK, Patel MR, Perera D, Pijls NHJ. Usefulness of Intra-aortic Balloon Pump Counterpulsation. Am J Cardiol. 2016;117(3):469–76.

Mégarbane B, Deye N, Malissin I, Baud FJ. Usefulness of the serum lactate concentration for predicting mortality in acute beta-blocker poisoning. Clin Toxicol. 2010;48(10):974–8.

Jones CM, McAninch JK. Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines. Am J Prev Med. 2015;49(4):493–501.